期刊文献+

中药溻渍结合西药对强直性脊柱炎化验指标临床研究 被引量:4

Clinical research of traditional Chinese medicine decoction combined with western medicine on ankylosing spondylitis stain assay index
暂未订购
导出
摘要 目的观察中药溻渍结合来氟米特治疗强直性脊柱炎的临床疗效。方法选取本院2011年4月~2012年4月强直性脊柱炎患者80例,随机分两组,中药溻渍结合来氟米特治疗患者40例为观察组,仅用来氟米特治疗患者40例为对照组,疗程60d。治疗后分析临床指标与临床疗效。结果治疗组有效率95%,对照组有效率84%,差异具有统计学意义(P〈0.05),治疗组在改善疼痛和功能活动,炎症指标血沉,C反应蛋白降低方面优于对照组(P〈0.05)。结论中药溻渍结合来氟米特治疗强直性脊柱炎在改善疼痛和功能活动有所好转,炎症指标血沉,C反应蛋白降低。 Objective To observe clinical effect of traditional Chinese medicine decoction combined with leflunomide on ankylosing spondylitis. Methods 80 patients with ankylosing spondylitis were selected in hospital from April 2011 to Apri 2012, who were randomly divided into two groups. 40 patients treated traditional Chinese medicine decoction combined with leflunomide as observation group. 40 patients treated leflunomide as control group. Course of treatment was 60 days. Clinical indicators and clinical efficacy were analyzed. Results Effective rate in observation group was 95%. Effective rate in control group was 84%. Difference was significant(P 〈 0.05).Observation group in improving pain and fundtional activities, inflammation index ESR, C reactive protein reduction were better than control group (P 〈 0.05). Conclusion Traditional Chinese medicine decoction combined with leflunomide in treatment of ankylosing spondylitis is better in improving pain and functional activities, inflammation index erythrocyte sedimentation rate, reduced C reactive protein.
作者 高金良
出处 《中国医药科学》 2013年第20期75-76,共2页 China Medicine And Pharmacy
关键词 强直性脊柱炎 中药溻渍 来氟米特 Ankylosing spondylitis Traditional Chinese medicine decoction stains Leflunomide
  • 相关文献

参考文献5

二级参考文献25

  • 1李永敢.强直性脊柱炎的诊断与治疗[J].广西医学,2006,28(1):149-150. 被引量:21
  • 2王建明,阎小萍,王昊,罗薇,马骁.补肾强督方治疗强直性脊柱炎患者259例临床研究[J].中医杂志,2006,47(6):433-435. 被引量:26
  • 3邓长财,鞠中斌.张鸣鹤治疗活动期强直性脊柱炎经验探讨[J].山东中医药大学学报,2006,30(5):372-373. 被引量:16
  • 4阎小萍,朱俊岭,颜珏,孔维萍,路平,陶庆文.补肾强督方治疗强直性脊柱炎骨质疏松、骨量减少102例临床观察[J].中华中医药杂志,2007,22(8):571-573. 被引量:22
  • 5Baraliakos X,Braun J. Spondyloarthritides[J].{H}BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY,2011,(06):825-842.
  • 6Braun J,Bollow M,Neure L,et a1. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis[J].{H}ARTHRITIS AND RHEUMATISM,1995,(04):499-515.
  • 7Gorman JD,Sack KE,Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha[J].{H}New England Journal of Medicine,2002,(18):1349-1356.
  • 8Brandt J,Khariouzov A,Listing J. Six-month results of a double-blind,placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis[J].{H}ARTHRITIS AND RHEUMATISM,2003,(06):1667-1675.
  • 9Rychly DJ,Dipiro JT. Infections associated with tumor necrosis factor alpha antagonists[J].{H}PHARMACOTHERAPY,2005,(09):1181-1192.
  • 10Wang L,Trousdale RT,Ai Set al.Dislocation aftertotal hip arthroplasty among patients withdevelopmental dysplasia of the hip[].JArthroplasty.2012

共引文献46

同被引文献35

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部